CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation. - Wikidata - wikimedia - TriplyDB

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.

http://www.wikidata.org/entity/Q36384883

about

Maraviroc: a review of its use in HIV infection and beyond Current and emerging strategies for the prevention of graft-versus-host disease The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).Snai2 and Snai3 transcriptionally regulate cellular fitness and functionality of T cell lineages through distinct gene programs.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.The role of chemokines in acute and chronic hepatitis C infection.Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models.Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.

P2860

Q26778504-AF48E7CB-E38B-422F-B6A9-2842E4401168 Q27016541-56955915-45C8-4414-A311-E2E7D96F272E Q34570969-C74EE476-5EBB-4141-AFC4-5325AB3BFCEF Q34640239-302B5B47-FB96-48FC-9998-F1214AC0586D Q35755674-B7A8899D-BB72-42A3-B2F8-BE8EFA03A2D7 Q36445685-4602F740-9D74-4CE1-A934-DB54A5BCC20C Q36711801-7F9645C8-E267-452C-BEE9-748A98A89857 Q36891433-E729DAF5-A63D-433E-B939-FC1BBDBFC1F8 Q37215167-AB013933-6260-4B26-9E3D-823C85A00AF7 Q37445265-ECE3025F-364E-4114-959E-6EC9AE153802 Q37452305-EF281537-FD1D-4748-A84D-40ECACE2336A Q37989141-34061A8F-3DB5-4A54-92AD-46F44A005128 Q38129709-97755625-515B-41A0-9467-7B59066AF04D Q38202155-66728A50-4297-4F24-8F53-F0C448E9F5DF Q39122603-4EF8308D-61ED-4039-B1DC-34EF3BDD905C Q39595063-EE01FA7D-B012-49DA-9C36-5F472791D29E Q40943412-167ADC98-5380-404E-A525-13BB66B64EB2 Q44291160-D149E853-6355-4436-9203-2A78912A64FD Q49954477-CF12EBB3-B137-4200-946F-A2DC528B7CC8 Q53646949-2F0707AA-1604-4C5C-A951-D40FB031158B

P2860

CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.

http://www.wikidata.org/entity/Q36384883

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@ast

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@en

type

label

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@ast

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@en

prefLabel

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@ast

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@en

P1433

Q36384883-6D3F2A4C-541D-4AF0-A669-19A64640B627

P1476

Q36384883-73C864A4-608E-4828-9669-229D0C8F4A41

P2093

Q36384883-0A503539-FA53-4B4C-B3BB-79D5B61FDDBA

Q36384883-0C5B8343-C491-49A5-933D-A17F1C9D31A9

Q36384883-1D8FEBC4-5BD8-452A-ACB4-2DCF28E5F78D

Q36384883-24D887A3-218B-4505-9A70-50690D72AEF9

Q36384883-39AE9EF7-8CE4-4772-A06B-EBEF278C077C

Q36384883-48B40846-2C96-4723-B76F-FE98D2D3D597

Q36384883-621369CE-30F1-430C-B64D-964DCEC68F50

Q36384883-95867FA2-0517-4752-AD2D-902318AD7BE9

Q36384883-B9370520-65C4-4574-9096-FD5F6B6C73F5

Q36384883-BF0CB901-EEDD-4924-8D27-EA0E38DBD9E6

P2860

Q36384883-0B6893C4-7E7B-44D4-8A35-E73B9E407919

Q36384883-10E4FEF4-89B3-4D49-B05D-3F5A15BB3922

Q36384883-1398BC3B-0EA5-44E0-855F-1527B6463D49

Q36384883-2CAAFB06-B010-4BE0-8A15-8AB5531B2946

Q36384883-2DF6C35E-F85F-4F1B-BD1B-EDF81BE6E981

Q36384883-31B32938-7E44-4DFF-ADE3-9530B58472E2

Q36384883-34920189-A142-4F13-A75E-E03F880819E0

Q36384883-39961FC1-E6A8-40B5-8D6D-C65887CF7154

Q36384883-3BC49AB3-3953-42D2-A849-2218158B340A

Q36384883-4AE0B423-BAD4-4E76-B468-D63E9A704524

P304

Q36384883-16AEAB23-F326-40DF-9E6B-57E36E6EA356

P31

Q36384883-C294EC18-D678-4F74-BA4E-0404B9EE544F

P356

Q36384883-0A1CAA19-5AF0-4B73-960A-CD85531BFF1C

P407

Q36384883-D8B4BFB0-846D-4084-9E93-FE92BD9C4DEB

P433

Q36384883-128AA602-7E81-4483-8B9A-046FB7CC9E09

P478

Q36384883-BD4E73E8-B81B-44AA-8441-6266F9195504

P577

Q36384883-2392B6AE-7347-4850-894F-443327B60A6B

P5875

Q36384883-C12F7ACF-EC1C-46AD-9592-77E5BC73AE8A

P698

Q36384883-693A90D0-4331-456E-9FDC-8AD3001E3867

P932

Q36384883-F14273EA-3D7F-43CB-A3D6-492AD099BCF2

P356

BLOOD-2007-05-087403

P1433

P1476

CCR1/CCL5 (RANTES) receptor-li ...... ing stem-cell transplantation.

@en

P2093

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Clare E Rogers

http://www.w3.org/2001/XMLSchema#string

Daphne T Deurloo

http://www.w3.org/2001/XMLSchema#string

David A Hanauer

http://www.w3.org/2001/XMLSchema#string

David Adams

http://www.w3.org/2001/XMLSchema#string

Gerhard C Hildebrandt

http://www.w3.org/2001/XMLSchema#string

Ines A Silva

http://www.w3.org/2001/XMLSchema#string

Jacki M Fisher

http://www.w3.org/2001/XMLSchema#string

Kenneth R Cooke

http://www.w3.org/2001/XMLSchema#string

Krystyna M Olkiewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES

Transcriptional regulation of RANTES expression in T lymphocytes

CCR1 and CC chemokine ligand 5 interactions exacerbate innate immune responses during sepsis

Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection

RANTES plays an important role in the evolution of allograft transplant-induced fibrous airway obliteration

Chemokines: a new classification system and their role in immunity

Chemokines--chemotactic cytokines that mediate inflammation

The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.

Pathophysiologic mechanisms of acute graft-vs.-host disease.

P304

3447-3455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-05-087403

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6197836

http://www.w3.org/2001/XMLSchema#string

P698

17641205

http://www.w3.org/2001/XMLSchema#string

P932

2200916

http://www.w3.org/2001/XMLSchema#string